These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Aminoglycoside ototoxicity. An update, with implications for all drug therapies. Johnson JT; Kamerer DB Postgrad Med; 1985 Apr; 77(5):131-4, 138. PubMed ID: 3872449 [No Abstract] [Full Text] [Related]
23. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201 [TBL] [Abstract][Full Text] [Related]
25. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation. Fang J; Wu H; Zhang J; Mao S; Shi H; Yu D; Chen Z; Su K; Xing Y; Dong H; Shi H Biomed Pharmacother; 2022 Jun; 150():113071. PubMed ID: 35658237 [TBL] [Abstract][Full Text] [Related]
26. Genetic factors in aminoglycoside toxicity. Fischel-Ghodsian N Pharmacogenomics; 2005 Jan; 6(1):27-36. PubMed ID: 15723603 [TBL] [Abstract][Full Text] [Related]
29. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. Song BB; Sha SH; Schacht J Free Radic Biol Med; 1998 Jul; 25(2):189-95. PubMed ID: 9667495 [TBL] [Abstract][Full Text] [Related]
30. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Barclay ML; Kirkpatrick CM; Begg EJ Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956 [TBL] [Abstract][Full Text] [Related]
31. Berberine chloride protects cochlear hair cells from aminoglycoside-induced ototoxicity by reducing the accumulation of mitochondrial reactive oxygen species. Kim YR; Baek JI; Lee KY; Kim UK Free Radic Biol Med; 2023 Aug; 204():177-183. PubMed ID: 37119862 [TBL] [Abstract][Full Text] [Related]
33. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy. Periti P J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543 [TBL] [Abstract][Full Text] [Related]
34. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Wu WJ; Sha SH; McLaren JD; Kawamoto K; Raphael Y; Schacht J Hear Res; 2001 Aug; 158(1-2):165-78. PubMed ID: 11506949 [TBL] [Abstract][Full Text] [Related]
35. [Search for new methods of administering aminoglycoside antibiotics to attenuate side effects]. Nowak P Postepy Hig Med Dosw; 2000; 54(5):571-83. PubMed ID: 11146886 [TBL] [Abstract][Full Text] [Related]
36. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Schacht J; Talaska AE; Rybak LP Anat Rec (Hoboken); 2012 Nov; 295(11):1837-50. PubMed ID: 23045231 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Fischel-Ghodsian N; Prezant TR; Bu X; Oztas S Am J Otolaryngol; 1993; 14(6):399-403. PubMed ID: 8285309 [TBL] [Abstract][Full Text] [Related]
38. [Familial susceptibility to aminoglycoside ototoxicity due to the A1555G mutation in the mitochondrial DNA]. Gallo-Terán J; Morales-Angulo C; del Castillo I; Moreno-Pelayo MA; Mazón A; Moreno F Med Clin (Barc); 2003 Jul; 121(6):216-8. PubMed ID: 12882732 [TBL] [Abstract][Full Text] [Related]
39. N-Acetylcysteine in the prevention of ototoxicity. Tepel M Kidney Int; 2007 Aug; 72(3):231-2. PubMed ID: 17653228 [TBL] [Abstract][Full Text] [Related]